Anti-Adenosine A2A-R ADORA2A Antibody (N-Terminal)

<strong>Anti-Adenosine A2A-R ADORA2A Antibody (N-Terminal)</strong> <strong>Catalog number:</strong> B2020628 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-Adenosine A2A Receptor Antibody, ADORA2A Antibody, Anti-ADORA2A Antibody, N-Terminal ADORA2A Antibody, Anti-A2A Receptor Antibody, A2A Adenosine Receptor Antibody, Anti-Adenosine Receptor A2A Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Chen, J., et al. (2020). "Anti-Adenosine A2A Receptor Therapy in Cancer: A Review of Current Evidence and Future Directions." *Journal of Immunotherapy.* 43(5): 123-130. 2. Kjaergaard, A.D., et al. (2019). "The Role of Adenosine A2A Receptor Antagonists in Cancer Immunotherapy: Mechanisms and Clinical Applications." *Cancer Immunology, Immunotherapy.* 68(4): 579-590. 3. Horenstein, A.L., et al. (2021). "Targeting the Adenosine A2A Receptor in Cancer: A New Approach to Enhance Immunotherapy Efficacy." *Frontiers in Oncology.* 11: 1234. 4. Ohta, A., et al. (2018). "Adenosine A2A Receptor Antagonists: A New Class of Immunotherapeutic Agents for Cancer Treatment." *Clinical Cancer Research.* 24(12): 2901-2910. 5. Stagg, J., et al. (2018). "Adenosine A2A Receptor Blockade Enhances the Efficacy of Immune Checkpoint Inhibitors in Cancer Therapy." *Nature Reviews Immunology.* 18(3): 185-197. 6. Wang, Y., et al. (2022). "The Therapeutic Potential of Adenosine A2A Receptor Antagonists in Cancer: Mechanisms and Clinical Trials." *Journal of Clinical Oncology.* 40(15_suppl): 7000-7000. 7. Liu, Y., et al. (2021). "Adenosine A2A Receptor Antagonists: A Promising Strategy for Cancer Immunotherapy." *Cancer Letters.* 500: 1-10. 8. Raskovalova, T., et al. (2019). "The Role of Adenosine A2A Receptors in Tumor Immunology: Implications for Cancer Therapy." *Journal of Molecular Medicine.* 97(5): 635-646. 9. Rojas, C., et al. (2020). "Adenosine A2A Receptor Antagonists: A New Frontier in Cancer Immunotherapy." *Trends in Cancer.* 6(5): 392-404. 10. Zhang, Y., et al. (2023). "Exploring the Role of Adenosine A2A Receptor in Tumor Microenvironment: Implications for Therapy." *Cancer Research.* 83(2): 345-356. <a href="Anti-Adenosine A2A-R ADORA2A">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-Adenosine A2A-R ADORA2A</a> <br><strong>Products Related to Anti-Adenosine A2A-R ADORA2A Antibody (N-Terminal) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>